相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The PPARγ-dependent effect of flavonoid luteolin against damage induced by the chemotherapeutic irinotecan in human intestinal cells
Thaise Boeing et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2022)
Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women
Yousef Yousefzadeh et al.
MOLECULAR BIOLOGY REPORTS (2022)
Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats
Weiwei Yang et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2021)
The natural compound puerarin alleviates inflammation and apoptosis in experimental cell and rat preeclampsia models
Xiaoping Liang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Luteolin ameliorates inflammation and Th1/Th2 imbalance via regulating the TLR4/NF-κB pathway in allergic rhinitis rats
Jinhui Dong et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2021)
Luteolin attenuates hepatic injury in septic mice by regulating P2X7R-based HMGB1 release
Zhi-Hong Zhang et al.
FOOD & FUNCTION (2021)
Protective effects of luteolin against oxidative stress and mitochondrial dysfunction in endothelial cells
Hsiu- Chen et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
The bioflavonoid quercetin improves pathophysiology in a rat model of preeclampsia
Qinghua Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Quercetin attenuates reduced uterine perfusion pressure -induced hypertension in pregnant rats through regulation of endothelin-1 and endothelin-1 type A receptor
Xia Sun et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Preeclampsia Pathophysiology, Challenges, and Perspectives
Sarosh Rana et al.
CIRCULATION RESEARCH (2019)
Trophoblast-Specific Expression of Hif-1α Results in Preeclampsia-Like Symptoms and Fetal Growth Restriction
Renee E. Albers et al.
SCIENTIFIC REPORTS (2019)
Luteolin attenuates acute lung injury in experimental mouse model of sepsis
Soya Rungsung et al.
CYTOKINE (2018)
Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies
Nur Aziz et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Luteolin Inhibits Vascular Smooth Muscle Cell Proliferation and Migration by Inhibiting TGFBR1 Signaling
Yu-Ting Wu et al.
FRONTIERS IN PHARMACOLOGY (2018)
Luteolin-mediated Kim-1/NF-kB/Nrf2 signaling pathways protects sodium fluoride-induced hypertension and cardiovascular complications
Ademola Adetokunbo Oyagbemi et al.
BIOFACTORS (2018)
RNAi modulation of placental sFLT1 for the treatment of preeclampsia
Anton A. Turanov et al.
NATURE BIOTECHNOLOGY (2018)
All Hypertensive Disorders of Pregnancy Increase the Risk of Future Cardiovascular Disease
Jane Tooher et al.
HYPERTENSION (2017)
Relationship between hypoxia and downstream pathogenic pathways in preeclampsia
Henri Augusto Korkes et al.
HYPERTENSION IN PREGNANCY (2017)
Luteolin: A Flavonoid that Has Multiple Cardio-Protective Effects and Its Molecular Mechanisms
Yuanyuan Luo et al.
FRONTIERS IN PHARMACOLOGY (2017)
Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells
Yohan Seo et al.
PLOS ONE (2017)
Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia
Ravi Thadhani et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies
Emily Bartsch et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies
Emily Bartsch et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Luteolin Ameliorates Hypertensive Vascular Remodeling through Inhibiting the Proliferation and Migration of Vascular Smooth Muscle Cells
Jie Su et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Placenta Growth Factor Induces Invasion and Activates p70 during Rapamycin Treatment in Trophoblast Cells
Allison Knuth et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2015)
Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1α pathway
Sarosh Rana et al.
FASEB JOURNAL (2014)
Epidemiology of Obstetric-Related ICU Admissions in Maryland: 1999-2008
Jonathan P. Wanderer et al.
CRITICAL CARE MEDICINE (2013)
Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state
Roberto Romero et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
Sarosh Rana et al.
CIRCULATION (2012)
Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1
Julio Mateus et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
Ravi Thadhani et al.
CIRCULATION (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosis
Kyung Pyo Kang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Reduction of Lipid Accumulation in HepG2 Cells by Luteolin is associated with Activation of AMPK and Mitigation of Oxidative Stress
Jin-Feng Liu et al.
PHYTOTHERAPY RESEARCH (2011)
Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model
Keiichi Kumasawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Effects of Hypoxia-Inducible Factor-1α Overexpression in Pregnant Mice Possible Implications for Preeclampsia and Intrauterine Growth Restriction
Reshef Tal et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model
Astrid Bergmann et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5
Margaret C. Hogan et al.
LANCET (2010)
Oxidative Stress Contributes to Soluble Fms-Like Tyrosine Kinase-1 Induced Vascular Dysfunction in Pregnant Rats
Jason P. Bridges et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Hypertensive Disorders and Severe Obstetric Morbidity in the United States
Elena V. Kuklina et al.
OBSTETRICS AND GYNECOLOGY (2009)
Loss of E-cadherin promotes ovarian cancer metastasis via alpha(5)-integrin, which is a therapeutic target
Kenjiro Sawada et al.
CANCER RESEARCH (2008)
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Yong Lin et al.
CURRENT CANCER DRUG TARGETS (2008)
The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
Hilary A. Kenny et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia
Zhihe Li et al.
HYPERTENSION (2007)
Let-7 expression defines two differentiation stages of cancer
Scott Shell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice
Fangxian Lu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Infant growth and stroke in adult life the Helsinki birth cohort study
Clive Osmond et al.
STROKE (2007)
Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1
Ori Nevo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
National estimates for maternal mortality:: an analysis based on the WHO systematic review of maternal mortality and morbidity -: art. no. 131
AP Betrán et al.
BMC PUBLIC HEALTH (2005)
Latest advances in understanding preeclampsia
CW Redman et al.
SCIENCE (2005)
The developmental origins of the metabolic syndrome
PD Gluckman et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae
A Rajakumar et al.
PLACENTA (2004)
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia
S Ahmad et al.
CIRCULATION RESEARCH (2004)
Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia
K Koga et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Impaired oxygen-dependent reduction of HIF-1α and -2α proteins in pre-eclamptic placentae
A Rajakumar et al.
PLACENTA (2003)
Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer
PM Kris-Etherton et al.
AMERICAN JOURNAL OF MEDICINE (2002)
分享论文
